The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
25874340 |
37 |
Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines. |
University of Catania |
24021581 |
72 |
Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position. |
Queen'S University |
23867390 |
37 |
Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties. |
University of Catania |
17339115 |
32 |
Heme oxygenase inhibition by 2-oxy-substituted 1-(1H-imidazol-1-yl)-4-phenylbutanes: effect of halogen substitution in the phenyl ring. |
Queen'S University |
16821802 |
30 |
Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors. |
Queen'S University |
18798608 |
3 |
X-ray crystal structure of human heme oxygenase-1 in complex with 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors. |
Queen'S University |
15713406 |
22 |
Synthesis and evaluation of azalanstat analogues as heme oxygenase inhibitors. |
Queen'S University |
30784878 |
40 |
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application. |
University of Catania |
31550661 |
74 |
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors. |
University of Catania |
30261468 |
20 |
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines. |
University of Catania |
29454190 |
44 |
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors. |
University of Catania |
10336515 |
3 |
Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist. |
Banyu Pharmaceutical |
10215672 |
11 |
Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. |
Taisho Pharmaceutical |